![Susan D. Wyrick](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Career history of Susan D. Wyrick
Former positions of Susan D. Wyrick
Companies | Position | Start | End |
---|---|---|---|
OncoGenex Pharmaceuticals, Inc.
![]() OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | Comptroller/Controller/Auditor | 2013-01-31 | 2014-06-10 |
Training of Susan D. Wyrick
University of Washington | Undergraduate Degree |
Statistics
International
United States | 3 |
Operational
Comptroller/Controller/Auditor | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
OncoGenex Pharmaceuticals, Inc.
![]() OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | Health Technology |
- Stock Market
- Insiders
- Susan D. Wyrick
- Experience